in order to assess the actual degree of activation of the coagulation and fibrinolytic systems in diabetics , plasma levels of thrombin-antithrombin iii complex ( tat ) and plasmin-alpha 2-plasmin inhibitor complex ( pap ) were measured together with tissue-type plasminogen activator ( t-pa ) and plasminogen activator inhibitor ( pai-1 ) in 18 patients with dm ( three patients with type i dm and 15 with type ii dm ) .
C0011849
dm
C0011860
type